Developments in the pharmacology and therapeutics of parkinsonism.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D009411:Nerve Endings / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D011954:Receptors, Dopamine
D018377:Neurotransmitter Agents; D011954:Receptors, Dopamine; D000262:Adenylyl Cyclases; D004298:Dopamine